Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review

Byung Soo Kim, Emanual Maverakis, Clarie Alexanian, Jenny Z. Wang, Siba P. Raychaudhuri

Research output: Contribution to journalReview article

Abstract

Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors.

Original languageEnglish (US)
JournalJournal of Cutaneous Medicine and Surgery
DOIs
StateAccepted/In press - Jan 1 2020

Keywords

  • anti-TNF therapy
  • herpes zoster
  • TNF antagonists
  • TNF inhibitors
  • vaccination
  • varicella zoster virus

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Fingerprint Dive into the research topics of 'Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review'. Together they form a unique fingerprint.

  • Cite this